Skip to main content

Y Hayashi

First name:
Y
Last name:
Hayashi
Hayashi, Y., Sexton, T., Dejima, K., Perry, D., Takemura, M., Kobayashi, S., … Harrison, D. (2012). Glypicans regulate JAK/STAT signaling and distribution of the Unpaired morphogen. Development (Cambridge, England), 139(22), 4162-71. https://doi.org/10.1242/dev.078055
Shimada, A., Iijima-Yamashita, Y., Tawa, A., Tomizawa, D., Yamada, M., Norio, S., … Adachi, S. (2018). Risk-stratified therapy for children with FLT3-ITD-positive acute myeloid leukemia: results from the JPLSG AML-05 study. International Journal of Hematology. https://doi.org/10.1007/s12185-017-2395-x (Original work published 2018)
Kimura, A., Takemura, M., Serrero, G., Yoshikura, N., Hayashi, Y., Saito, K., & Inuzuka, T. (2018). Higher levels of progranulin in cerebrospinal fluid of patients with lymphoma and carcinoma with CNS metastasis. Journal of Neuro-Oncology. https://doi.org/10.1007/s11060-017-2742-z (Original work published 2018)
Hayashi, Y., Shimamura, A., Ishikawa, T., Fujiwara, Y., & Ichi, I. (2018). FADS2 inhibition in essential fatty acid deficiency induces hepatic lipid accumulation via impairment of very low-density lipoprotein (VLDL) secretion. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2018.01.064 (Original work published 2018)
Saxena, S., Purohit, A., Varney, M., Hayashi, Y., & Singh, R. (2018). Semaphorin-5A maintains epithelial phenotype of malignant pancreatic cancer cells. BMC Cancer, 18(1), 1283. https://doi.org/10.1186/s12885-018-5204-x (Original work published 2018)
Saxena, S., Hayashi, Y., Wu, L., Awaji, M., Atri, P., Varney, M., … Singh, R. (2018). Pathological and functional significance of Semaphorin-5A in pancreatic cancer progression and metastasis. Oncotarget, 9(5), 5931-5943. https://doi.org/10.18632/oncotarget.23644 (Original work published 2018)